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A B S T R A C T   
Background: Several endocrine-disrupting metals may affect thyroid function, but the few available studies of 
exposure during pregnancy and thyroid hormones are inconclusive. 
Objective: To explore if environmental exposure to cadmium (Cd), lead (Pb), and methylmercury (MeHg) impacts 
thyroid function in pregnancy, and interacts with iodine and selenium status. 
Methods: Women in a Swedish birth cohort provided blood and urine samples in early third trimester. Concen-
trations of erythrocyte Cd, Pb, and Hg (n = 544), urinary Cd and iodine (n = 542) and plasma selenium (n = 548) 
were measured using inductively coupled plasma-mass spectrometry. Free and total thyroxine (fT4, tT4) and 
triiodothyronine (fT3, tT3), and thyroid stimulating hormone (TSH), were measured in plasma (n = 548) with 
electrochemiluminescence immunoassays. Metal-hormone associations were assessed in regression models, and 
metal mixture effects and metal-nutrient interactions were explored in Bayesian kernel machine regression 
(BKMR). 
Results: In multivariable-adjusted regression models, a doubling of urinary Cd was associated with a mean in-
crease in tT4 of 2.7 nmol/L (95% CI: 0.78, 4.6), and in fT3 and tT3 of 0.06 pmol/L (0.02, 0.10) and 0.09 nmol/L 
(0.05, 0.13), respectively. A doubling of urinary Cd was associated with a − 0.002 (− 0.003, − 0.001) and − 0.03 
(− 0.05, − 0.02) decrease in the fT4:tT4 and fT3:tT3 ratio, respectively. A doubling of erythrocyte Hg (>1 µg/kg) 
was associated with a decrease in fT3 and tT3 by − 0.11 pmol/L (− 0.16, − 0.05) and − 0.11 nmol/L (− 0.16, 
− 0.06), respectively, and a − 0.013 (− 0.02, − 0.01) decrease in the fT3:fT4 ratio. BKMR did not indicate any 
mixture effect of toxic metals or interactions between metals and iodine or selenium in relation to the hormones. 
Conclusion: Our findings suggest that exposure to Cd and Hg, at levels globally prevalent through the diet, may 
affect thyroid function during pregnancy, independently of iodine and selenium levels. Further studies on po-
tential implications for maternal and child health are warranted.   
1. Introduction 
Thyroid hormones, thyroxine (T4) and triiodothyronine (T3), regu-
late the metabolism, growth, and development of the human body 
(Mullur et al. 2014). The active form of thyroid hormone is T3, which is 
mainly generated in peripheral tissue (about 80%; Robbins 1981) by de- 
iodination of the less active T4, the primary hormone produced in the 
thyroid gland under influence of thyroid-stimulating hormone (TSH). 
Through a negative feedback loop, reduced levels of T3 and T4 in the 
circulation stimulates the release of TSH from the pituitary gland, which 
augments production of T4 and T3. Most of the circulating T4 and T3 are 
bound to proteins, mainly thyroxine-binding globulin, leaving<1% of 
these hormones free and biologically active. Pregnancy requires 
increased levels of thyroid hormones as the fetus relies entirely on 
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maternal thyroid hormone production until mid-gestation, when the 
fetal thyroid starts producing its own hormones (Zimmermann 2009; 
Obregon et al. 2007). Still, the maternal supply of iodine continues 
throughout gestation to maintain fetal T4 levels. Both low and elevated 
thyroid hormones levels in pregnancy may adversely impact fetal 
development (Korevaar et al. 2016). Even in women with no overt 
thyroid disease, particularly elevated free T4 levels have been associated 
with impaired fetal growth and neurodevelopment (Johns et al. 2018; 
Korevaar et al. 2016; Leon et al. 2015; Medici et al. 2013). 
The toxic metals cadmium (Cd), lead (Pb), and methylmercury 
(MeHg) are commonly present in some of our most valuable food items 
and are known to affect fetal development, including cognitive function 
(EFSA 2010, 2012; Liu et al. 2019). All have pro-oxidant and endocrine 
disruptive properties, and experimental data suggest that exposure to 
these metals may interfere with thyroid function either by accumulation 
in the thyroid or by affecting the regulation (Iavicoli et al. 2009). 
However, epidemiological studies of toxic metal exposure and thyroid 
function are scarce and have mostly involved occupationally exposed 
individuals (Ellingsen et al. 2000; Krieg 2016; Rosati et al. 2016) or the 
general adult population, mainly in the U.S. (Chen et al. 2013; Yorita 
Christensen 2013; Luo and Hendryx 2014). Associations of multiple 
metals, including at least one of the toxic metals Cd, Pb and Hg, with 
thyroid function in pregnant women have been investigated in three 
recent Chinese studies (Guo et al. 2018; Sun et al. 2019; Wang et al. 
2020), one study from Puerto Rico (Rivera-Nunez et al. 2021), and two 
European studies (Llop et al. 2015; Ursinyova et al. 2012), with mixed 
results. None of the aforementioned studies explored potential in-
teractions with iodine and selenium status. It has been suggested that 
exposure to mixtures of thyroid hormone-disrupting toxicants in preg-
nancy in combination with iodine deficiency may aggravate the impact 
on fetal development (Demeneix 2020). Iodine is a component of T3 and 
T4, whereas selenium is an integral part of the deiodinases that activate 
or inactivate thyroid hormones. Consequently, an adequate intake of 
iodine and selenium during pregnancy is required for sufficient maternal 
production of thyroid hormones (Glinoer 1997; Krassas et al. 2010), as 
well as for the fetal production, initiated in mid-pregnancy (Obregon 
et al. 2007). Furthermore, selenium is a crucial part of the antioxidant 
enzymes protecting the thyroid from oxidative damage (Kohrle 2015). 
The present study aimed to elucidate the potential impact of low- 
level exposure, common through the diet, to Cd, Pb, and MeHg on 
thyroid hormone and TSH levels in pregnant women, and to explore 
potential interactions with both iodine and selenium. 
2. Methods 
2.1. Study population 
The present study is part of the prospective birth-cohort NICE 
(Nutritional impact on the Immunological Maturation during Childhood 
in relation to the Environment) in northern Sweden. As previously 
described (Barman et al. 2018), the primary aim of the NICE study is to 
assess how the early-life environment may influence immune matura-
tion and allergy development during early childhood. Secondary out-
comes include infant and child anthropometry and neurological 
development. The cohort was established between 2015 and 2018 in the 
catchment area of Sunderby Hospital in Norrbotten county in the very 
north of Sweden. Expecting parents received an information leaflet at 
their visit to the local maternity clinics, and at the routine ultrasound in 
gestational week 18–19 parents wishing to participate were given 
further information and an informed consent to sign at home and send 
back. Finally, to be included in the study, the parents had to be residents 
in the southern or eastern part of Norrbotten county, planning to give 
birth at Sunderby Hospital, and be able to communicate in written and 
spoken Swedish. 
A total of 655 pregnancies were included in the NICE cohort (Sup-
plementary Fig. S1), 18 of which were second pregnancies in already 
participating families. Only data from the first pregnancy were included 
in the present study, except for two families where the first child was 
stillborn (in gestational week 29 and 37, respectively), for which data 
only from the second pregnancy was included. We also excluded twin 
births (n = 3) and one mother that withdrew from the study. Of the 633 
eligible singleton pregnancies, we additionally excluded women with 
any notation in their pregnancy hospital records regarding thyroid 
dysfunction (i.e., hypothyroidism, hyperthyroidism, Graves’ disease, 
removed thyroid) and/or medication with any thyroid interfering drugs 
(n = 44). Of the remaining women, 548 had donated blood samples from 
which the plasma fraction was available for assessing thyroid bio-
markers (excluding one mother with an extreme TSH concentration of >
20 mIU/L), and the erythrocyte fraction (n = 544) and/or urine samples 
(n = 542) were available for trace element analyses. 
The study was approved by the Regional Ethical Review Board, 
Umeå, Sweden, and performed in accordance with the Helsinki decla-
ration. The participants were informed that they were free to withdraw 
from the study at any given time without further explanation. 
2.2. Sample collection 
At the local maternity health clinics, venous blood and spot urine 
samples were collected at around gestational week 29 (mean: 29; range: 
24–36), as previously described (Barman et al. 2018; Gustin et al. 2020). 
Blood samples were collected in both 10 mL EDTA tubes (Becton Dick-
inson, Plymouth, UK), for thyroid biomarkers and selenium analyses, 
and 6 mL trace element-free Na-heparin tubes (Greiner bio-one, 
Kremsmünster, Austria), for metal analyses. Spot urine samples (mid- 
stream) were collected in urine collection cups and then transferred to 
24-mL polyethylene bottles, both containers tested free of trace ele-
ments. All samples were stored at 4 ◦C at the local clinics until trans-
ported cold to the hospital laboratory the same or following workday. At 
the hospital laboratory, blood samples were centrifuged for 5 min at 
2400 rpm (Hettich Rotina 420, Hettich Lab Technology, Tuttlingen, 
Germany), and the erythrocyte and plasma fractions were separated. 
The plasma fraction was aliquoted to 1.4 mL polypropylene tubes 
(Micronic, Nordic Biolabs AB, Sweden). All samples were stored at − 20 
or − 80 ◦C until transported frozen to the Department of Clinical 
Chemistry at the University Hospital of Malmö, Sweden, for hormone 
analyses, or to Karolinska Institutet, Sweden, for trace element analyses. 
2.3. Thyroid biomarkers 
All hormone analyses were performed at the accredited laboratory of 
the Department of Clinical Chemistry at the University Hospital of 
Malmö, Sweden. The plasma samples, collected around gestational week 
29, were analyzed for free and total T4 (fT4, tT4) and free and total T3 
(fT3, tT3) via automated electrochemiluminescence immunoassays 
(ECLIA) by Roche Cobas (Roche Diagnostics, Solna, Sweden), consisting 
of a two-step immunometric-competitive technique followed by 
chemiluminescent emission measurement, according to the producer’s 
instructions. Plasma concentrations of TSH were analyzed using a one- 
step sandwich method with ECLIA (Roche Cobas, Roche Diagnostics, 
Solna, Sweden). 
2.4. Assessment of toxic metals and trace elements 
Metal exposure during pregnancy was assessed by concentrations of 
Cd, Pb, and total Hg in erythrocytes, and Cd also in urine. The majority 
of blood Cd and Pb is found in the erythrocytes (Carlson and Friberg 
1957; Schultze et al. 2014) and are therefore thought to reflect the 
exposure of a few months, related to the lifespan of erythrocytes (She-
min and Rittenberg 1946). We also measured the Cd concentration in 
urine, as this is a recognized long-term biomarker of Cd exposure, due to 
the accumulation of Cd in the kidneys with a half-life of 10–45 years 
(Akerstrom et al. 2013; Amzal et al. 2009). Like Cd and Pb, blood MeHg 
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is mainly localized to the erythrocytes, and > 90% of the erythrocyte Hg 
consists of MeHg, with small variations between individuals and expo-
sure levels (Berglund et al. 2005). The small fraction of inorganic Hg 
present in erythrocytes is largely due to demethylation of MeHg (Ber-
glund et al. 2005). The erythrocyte metal concentrations were measured 
by weight (µg/kg), and urinary Cd by volume (µg/L). 
Maternal iodine status was assessed by concentrations in urine (the 
main route of iodine excretion), which is considered a valid biomarker of 
iodine status on a population level (Andersson et al., 2007). Selenium 
status was measured by concentrations in plasma, the most commonly 
used biomarker (Burk and Hill 2015), reflecting intake over the past 
week(s) (Neve 1991). The women’s plasma concentrations were 
measured by weight (µg/kg) and then converted to the more commonly 
used µg/L by multiplying the concentrations with the average density of 
plasma of 1.026 kg/L (Lentner 1981). 
Concentrations of toxic metals and essential trace elements in 
erythrocytes, urine, and plasma were measured with inductively 
coupled plasma mass spectrometry (ICP-MS; Agilent 7700x, Agilent 
Technologies, Tokyo, Japan), equipped with an octopole reaction sys-
tem. Cadmium (isotope 111), iodine (isotope 127) and selenium (isotope 
78) were measured in helium mode, whereas Pb (isotope 208) and Hg 
(isotope 202) were measured in no gas mode. Prior to the ICP-MS ana-
lyses, erythrocyte and plasma samples were diluted 1:25 in an alkali 
solution [2% (w/v)1-butanol, 0.05% (w/v) EDTA, 0.05% (w/v) Triton 
X-100, 1% (w/v) NH4OH and 20 µg/L internal standard (germanium, 
rhodium, lutetium, and iridium)] and vortex mixed, then sonicated for 
five minutes and centrifuged at 1000 rpm for two minutes (MSE 
centrifuge, Super Minor, MSE (UK) Ltd, London, England) (Lu et al. 
2015). The limit of detection (LOD; calculated as 3 times the standard 
deviation of the blank concentrations) was 0.0037 µg/kg, 0.11 µg/kg, 
0.010 µg/kg, and 0.36 µg/L for Cd, Pb, Hg, and selenium, respectively. 
No sample had a concentration below the LOD for either Cd, Pb, or se-
lenium, but two samples had a concentration below the LOD for Hg, 
which were replaced by LOD/√2. Quality control of the ICP-MS ana-
lyses of erythrocyte metals was performed by the inclusion of two 
commercial reference materials of whole blood, and the analyses of 
plasma selenium included two commercial reference materials of serum, 
in each run and obtained values were in good agreement with the 
reference values (Supplementary Table S1). 
Prior to ICP-MS analyses of urinary Cd, the urine samples were 
diluted 1:10 in 1% nitric acid (67–69% w/w, NORMATOM®, VWR, 
Butterworth, UK). The LOD was 0.003 µg/L, and no urine sample had a 
Cd concentration below this limit. Urine samples analyzed for iodine 
concentrations were diluted 1:10 in 0.1 % ammonium hydroxide solu-
tion (NH4OH; 25 % suprapur, Merck, Darmstadt, Germany) (Rydbeck 
et al. 2014). The LOD was 1.85 µg/L, and no sample had an iodine 
concentration below this limit. For the measurements of Cd and iodine, 
we included two commercial urine reference materials in each run, and 
there was good agreement between obtained values and recommended 
reference values (Supplementary Table S1). To compensate the urinary 
concentrations for the variation in urine dilution, the specific gravity of 
each urine sample (SGsample) was measured with a digital refractometer 
(EUROMEX RD712, Clinical Refractometer, Holland), and all urinary 
concentrations (C) were then adjusted (Cadj) to the mean specific gravity 
(SGmean) of 1.017, using the following formula: Cadj = C × (SGmean− 1)/ 
(SGsample− 1), as reported previously (Nermell et al. 2008). 
2.5. Covariates 
Information on maternal age (years), early-pregnancy body mass 
index [BMI (kg/m2); calculated based on body weight (kg) and height 
(cm) recorded at registration at the maternity clinic in the first 
trimester], parity (number of previous births), education (elementary 
school, high school, or university), pre-pregnancy smoking (never, 
sometimes, or daily), pre-pregnancy snuff (non-smoking tobacco) use 
(never, sometimes, or daily), and pre-pregnancy alcohol consumption 
(never, sometimes, or daily) was obtained from the hospital records. We 
also obtained information on early pregnancy use of tobacco and alcohol 
consumption, but since very few, or none, of the women used tobacco or 
alcohol during pregnancy, this was not further explored. Since thyroid 
hormone and TSH levels may fluctuate depending on the season (Mahwi 
and Abdulateef 2019; Wang et al. 2018), the dates of the collection of 
the maternal blood samples were classified into four seasons (spring: 1 
March-31 May; summer: 1 June-31 August; fall: 1 September-30 
November; winter: 1 December-28 or 29 February). 
2.6. Statistical analyses 
Statistical analyses were performed using the software Stata/IC 15.0 
(StataCorp, TX, USA) or R 3.6.2 (R Core Team 2019). P-values and 
sharpened q-values below 0.05 were considered statistically significant, 
but we also considered the consistency and robustness of the results. 
Bivariate associations between the maternal metal concentrations 
(erythrocyte concentrations of Cd, Pb and Hg, and urinary Cd), hor-
mones (plasma concentrations of fT4, tT4, fT3, tT3, and TSH), hormone 
ratios (fT4:tT4, fT3:tT3, and fT3:fT4), and all potential covariates were 
initially explored with either Spearman rank test (continuous variables), 
Mann-Whitney U test or Kruskal-Wallis test (continuous and categorical 
variables), or chi-square test (categorical variables). 
Model covariates were selected with the aid of a directed acyclic 
graph (DAG; Supplementary Fig. S2), where the assumed causal re-
lationships between exposures, outcomes, and covariates were visual-
ized. As maternal weight and height were correlated with BMI, only BMI 
was explored as a covariate in the DAG. Similarly, maternal pre- 
pregnancy smoking and use of snuff were associated but only smoking 
was associated with the exposures and outcomes and therefore kept as a 
covariate. Exposure to Pb has previously been linked to alcohol con-
sumption (Wennberg et al 2017), but Pb and alcohol intake were not 
associated among the present mothers (nor was alcohol use associated 
with any of the other exposures or the outcomes), so alcohol intake was 
not included in the DAG. Gestational week at sampling, and season at 
sampling, were identified as potential confounders in the DAG, but 
gestational week at sampling was not associated with any of the 
measured hormones, and season of sampling only very weakly associ-
ated with tT3. Therefore, these were not adjusted for in the main ana-
lyses, but were included in the sensitivity analyses (described below). 
Thus, the main models were adjusted for parity (two groups: ‘0′ and 
‘>0′), maternal education (two groups: ‘lower than university’ and 
‘university’), and maternal pre-pregnancy smoking (two groups: ‘never’ 
and ‘sometimes or daily’). We then created additional models also 
adjusted for maternal urinary iodine (µg/L; log2-transformed) and 
plasma selenium (µg/L) concentrations. 
All the measured metal concentrations were log2-transformed (due 
to right-skewness), and linearity of the log2-transformed concentrations 
with the maternal hormone concentrations, and hormone ratios, was 
checked with scatter plots with moving average Lowess curves. These 
indicated a tendency of non-linear relationships for some of the associ-
ations. Therefore, linearity of the metal-hormone associations was sta-
tistically tested using generalized additive models (GAMs), with two 
degrees of freedom and adjusted as the main models, and a p-gain < 0.05 
was considered to indicate non-linearity. The associations suggested to 
be non-linear were erythrocyte and urinary Cd with TSH, and erythro-
cyte Hg with fT3, tT3, and the fT3:fT4 ratio. These associations were 
further explored by comparing the Akaike information criterion (AIC; an 
estimator of relative model quality) between i) a linear model, ii) a 
model including a quadratic exposure term, and iii) a model including a 
spline knot for which the position was visually determined by plotting 
the covariate-adjusted association of the GAM models (Supplementary 
Fig S3A-E). The model with the lowest AIC (highest quality) was then 
kept in the main analyses. The quadratic exposure term-model had the 
lowest AIC for the association of erythrocyte Cd with TSH, while the 
spline models had the lowest AIC for urinary Cd with TSH (spline knot at 
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the Cd concentrations of 0.09 µg/L; Supplementary Fig. S3B), and for Hg 
with fT3, tT3, and fT3:fT4 (spline knots at the Hg concentrations of 1 µg/ 
kg; Fig S3C-E). All other associations between the metals and hormones, 
and hormone ratios, appeared to be linear and were therefore modelled 
with linear regression. 
Due to the multiple testing (four exposure biomarkers against eight 
outcomes), we computed sharpened false discovery rate (FDR) q-values 
for the main regression analyses, using Michael Anderson’s code 
(described in Anderson 2008). The interpretation of the sharpened q- 
values is similar to that of p-values as they represent the probability of 
type I error. 
In sensitivity analyses, we further explored the associations of the 
toxic metal concentrations and the hormones without any covariate 
adjustment (crude model) and by including all potential confounders 
identified in the DAG (i.e. additionally adjusting for gestational week at 
sampling and season at sampling; Supplementary Fig. S2), and we also 
conducted sub-group analyses of only never-smoking women. 
For all regression models, missing covariate data was imputed by 
multiple imputation by chained equations (MICE) in Stata (Royston 
2004), which can impute data for categorical variables. Separate 
imputation models were created for each regression model, including all 
variables (transformed if transformed in the regression model) that were 
included in the regression model. For models including gestational week 
at sampling, maternal early-pregnancy BMI was also included in the 
imputation model (but not in the regression model), as an auxiliary 
variable, due to it being associated with missingness of gestational week 
at sampling. The number of imputed data sets was set to 50 for all 
models. The proportion of missing observations were 1.1% (n = 6) for 
maternal education, 1.1% (n = 6) for parity, and 1.5% (n = 8) for 
maternal pre-pregnancy smoking. In models adjusted also for gesta-
tional week at sampling, the proportion of missing data for this variable 
was 7.3% (n = 40). In models with exposure assessed in erythrocytes and 
adjusted for urinary iodine, 1.1% (n = 6) of the urinary iodine obser-
vations were imputed. We chose to not impute the main exposures (toxic 
metal concentrations). 
Lastly, we explored possible interactions between urinary Cd, 
erythrocyte Pb, and erythrocyte Hg in relation to the maternal hor-
mones, as well as any potential joint effects of mixed exposure to all 
three metals, with Bayesian kernel machine regression (BKMR; Bobb 
et al. 2015) using the R package bkmr (Bobb 2017). We conducted the 
BKMR with centered and scaled metal concentrations (the concentration 
subtracted by the mean and divided by the standard deviation), applying 
the option of variable selection and 50 000 iterations by the Markov 
chain Monte Carlo algorithm. Due to the BKMR being sensitive to out-
liers, extreme concentrations of urinary Cd (>0.63 µg/L; n = 5), eryth-
rocyte Pb (>69 µg/kg; n = 2) and Hg (>8.3 µg/kg; n = 1) were omitted 
from the analyses, as well as six women who had not provided both urine 
and erythrocyte samples. All BKMR analyses were adjusted for the same 
covariates as our main regression model, defined above. Multiple 
imputation could not be performed for the BKMR, why women with 
missing data on parity (n = 6) and pre-pregnancy smoking (n = 7) were 
additionally excluded, leaving a total of 517 women included (Supple-
mentary Fig. S1). An additional BKMR model was then created to 
explore potential interactions between the metals and the women’s 
iodine and selenium levels. Like the metals, the urinary iodine and 
plasma selenium concentrations were centered and scaled and included 
among the exposure variables in the BKMR. Extreme iodine (>382 µg/L) 
concentrations were removed in the analyses (n = 10), leaving a final 
sample of 507 women. In the BKMR, interactions were defined as the 
difference in the predicted single-exposure effect when the other expo-
sures were fixed at different percentiles (10th, 50th, and 90th percentile) 
and the results were visualized in plots, where non-parallel dos-
e–response curves would indicate that the single-exposure effect differed 
depending on the level of the other exposures. Joint exposure effects 
were assessed in the BKMR as the predicted change in the outcome when 
all metals were held at particular percentiles, compared to when all 
metals were held at their median concentration, also visualized in plots. 
3. Results 
3.1. Background characteristics 
General characteristics of the 548 women included in the study are 
presented in Table 1 (non-imputed data). The mean age was 30 years, 
with a mean early-pregnancy BMI of 24.4 kg/m2. Almost half of the 
women were nulliparous (49%) and 71% had a university education. 
Few of the women smoked, 6.7% prior to pregnancy and 1.3% in early 
pregnancy. Most women (75%) reported occasional alcohol consump-
tion prior to pregnancy, while none reported any alcohol consumption 
in early pregnancy. The median urinary iodine concentration among the 
women was 113 µg/L (range: 29–512 µg/L), and the median plasma 
selenium concentration was 67 µg/L (range: 32–130 µg/L). 
3.2. Concentrations of cadmium, lead, and mercury in erythrocytes and 
urine 
The median concentrations of erythrocyte Cd, Pb, and Hg among the 
pregnant women were 0.29 µg/kg, 11 µg/kg, and 1.5 µg/kg, respec-
tively. The median urinary Cd concentration was 0.10 µg/L. Concen-
trations of the different metals were not strongly correlated 
(Supplementary Table S2), the strongest correlation was observed be-
tween erythrocyte and urinary Cd (rs: 0.43). Weak positive correlations 
were observed between erythrocyte Cd and Pb (rs: 0.16), erythrocyte Pb 
and Hg (rs: 0.12), and urinary Cd and erythrocyte Pb (rs: 0.10). Cd 
concentrations in erythrocytes were higher (p < 0.01) in pre-pregnancy 
smokers than among never-smoking women (median: 0.55 µg/kg and 
0.28 µg/kg, respectively; p < 0.01), the same was true for Cd in urine 
(median: 0.13 µg/L and 0.10 µg/L, respectively, p < 0.01). Erythrocyte 
Hg was slightly higher among women with a university education than 
among women with either an elementary or high school education 
Table 1 
Characteristics of the included mothers.  
Maternal characteristics n Median 
(5th-95th percentile) 
or % 
Age (y) 547 30 (23–39) 
Weight (kg) 531 68 (53–98) 
Height (cm) 548 167 (158–178) 
BMI (early pregnancy) 532 24.4 (19.4–34.6) 
Parity (% nulliparous) 542 49 
Education (% university education) 542 71 
Pre-pregnancy smoking (% yes) 540 6.7 
Gestational week at sample collection (weeks) 508 28.6 (27.3–32.1) 
Season at sampling (% spring/summer/fall/winter) 548 30/27/20/23 
fT4 (pmol/L) 548 12 (9.6–15) 
tT4 (nmol/L) 548 122 (94–154) 
fT3 (pmol/L) 548 4.1 (3.4–4.8) 
tT3 (nmol/L) 548 2.6 (1.9–3.4) 
TSH (mIU/L) 548 1.6 (0.61–3.3) 
fT4:tT4 ratio 548 0.10 (0.08–0.12) 
fT3:tT3 ratio 548 1.6 (1.3–1.9) 
fT3:fT4 ratio 548 0.33 (0.26–0.44) 
Erythrocyte Cd (µg/kg) 544 0.29 (0.14–0.77) 
Urinary Cd (µg/L)a 542 0.10 (0.04–0.26) 
Erythrocyte Pb (µg/kg) 544 11 (6.0–27) 
Erythrocyte Hg (µg/kg) 544 1.5 (0.29–4.2) 
Urinary iodine (µg/L)a 542 113 (53–306) 
Plasma selenium (µg/L)b 548 67 (46–93) 
Abbreviations: BMI, body mass index; Cd, cadmium; fT3, free triiodothyronine; 
fT4, free thyroxine; Hg, mercury; Pb, lead; TSH, thyroid stimulating hormone; 
tT3, total triiodothyronine; tT4, total thyroxine. 
a Concentrations adjusted to the mean specific gravity of 1.017. 
b Concentrations converted from µg/kg to µg/L by assuming a plasma density 
of 1.026 kg/L. 
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(median: 1.6 and 1.3 µg/kg, respectively; p < 0.001), but lower in pre- 
pregnancy smokers than never-smokers (median: 0.80 and 1.5 µg/kg, 
respectively; p < 0.001). 
3.3. Concentrations of thyroid biomarkers 
The mean concentration of fT4 and tT4 was 12 pmol/L (SD: 1.6) and 
123 nmol/L (SD: 19), respectively, and for fT3 and tT3 the mean con-
centrations were 4.1 pmol/L (SD: 0.44) and 2.6 nmol/L (SD: 0.44), 
respectively. The mean concentration of plasma TSH was 1.7 mIU/L (SD: 
0.88). The mean ratio of fT4:tT4 and fT3:tT3 was 0.10 (SD: 0.01) and 1.6 
(SD: 0.18), respectively. The mean ratio of fT3:fT4 was 0.34 (SD: 0.06). 
Among the measured hormones, fT3 and tT3 displayed the strongest 
correlation (rs: 0.74; Supplementary Table S2), followed by fT4 and tT4 
(rs: 0.68), and tT4 and tT3 (rs: 0.44). TSH was weakly and inversely 
correlated with both fT4 (rs: − 0.14) and tT4 (rs: − 0.10). For the hor-
mone ratios, the strongest correlation was observed between the fT4:tT4 
and fT3:tT3 ratios (rs: 0.80). 
3.4. Associations between metal exposure and thyroid biomarkers 
In the multivariable-adjusted regression analyses (Table 2), urinary 
Cd (long-term exposure marker) was linearly and positively associated 
with concentrations of tT4, fT3, and tT3; a doubling of urinary Cd was 
associated with a mean increase in tT4 of 2.7 nmol/L [95% CI: 0.78, 4.6 
(corresponding to a change of 0.14 SD)], fT3 of 0.06 pmol/L [95% CI: 
0.02, 0.10 (0.14 SD)], and tT3 of 0.09 nmol/L [95% CI: 0.05, 0.13 (0.21 
SD)]. Further, urinary Cd was non-linearly associated with TSH. Above 
the urinary Cd concentration of 0.09 µg/L, a doubling in Cd resulted in a 
mean increase in TSH of 0.16 mIU/L (95% CI: 0.02, 0.30), a change 
corresponding to 0.18 SD, but the association did not persist after FDR 
adjustment (sharpened q-value > 0.05). Urinary Cd was also inversely 
associated with the ratio of both fT4:tT4 and fT3:tT3, with a mean 
decrease in total:free hormone ratio of − 0.002 (95% CI: − 0.003, 
Table 2 
Multivariable-adjusted regression analyses of metal concentrations in erythrocytes (µg/kg; log2-transformed) and urine (µg/L; log2-transformed) with concurrent 
hormone levels in pregnancy.   
Multivariable-adjusted modelsa  
n B 95% CI p Sharpened q-valueb 
fT4 (pmol/L)      
Ery-Cd 544  0.012 (− 0.16, 0.19)  0.90  0.79 
U-Cd 542  0.015 (− 0.14, 0.17)  0.85  0.79 
Ery-Pb 544  0.014 (− 0.21,0.18)  0.89  0.79 
Ery-Hg 544  0.018 (− 0.089, 0.13)  0.74  0.71 
tT4 (nmol/L)      
Ery-Cd 544  0.37 (− 1.8, 2.5)  0.73  0.71 
U-Cd 542  2.7 (0.78, 4.6)  0.006  0.028 
Ery-Pb 544  0.90 (− 1.5, 3.3)  0.46  0.59 
Ery-Hg 544  − 0.89 (− 2.2, 0.42)  0.18  0.30 
fT3 (pmol/L)      
Ery-Cd 544  − 0.016 (− 0.064, 0.031)  0.50  0.59 
U-Cd 542  0.060 (0.017, 0.10)  0.007  0.028 
Ery-Pb 544  0.036 (− 0.018, 0.090)  0.19  0.30 
Ery-Hg < 1 µg/kg 148  0.010 (− 0.037, 0.057)  0.67  0.69 
Ery-Hg > 1 µg/kg 396  ¡0.11 (¡0.16, ¡0.052)  <0.001  0.003 
tT3 (nmol/L)      
Ery-Cd 544  − 0.010 (− 0.057, 0.037)  0.67  0.69 
U-Cd 542  0.092 (0.050, 0.13)  <0.001  0.003 
Ery-Pb 544  0.038 (− 0.015, 0.091)  0.16  0.29 
Ery-Hg < 1 µg/kg 148  0.002 (− 0.044, 0.048)  0.93  0.79 
Ery-Hg > 1 µg/kg 396  ¡0.11 (¡0.16, ¡0.055)  <0.001  0.003 
TSH (mIU/L)      
Ery-Cd 544  0.17 (− 0.013, 0.35)  0.069  0.16 
Ery-Cd^2 544  0.045 (− 0.009, 0.098)  0.10  0.20 
U-Cd < 0.09 µg/L 198  − 0.19 (− 0.40, 0.014)  0.067  0.16 
U-Cd > 0.09 µg/L 344  0.16 (0.023, 0.30)  0.022  0.062 
Ery-Pb 544  − 0.023 (− 0.13, 0.087)  0.68  0.69 
Ery-Hg 544  0.051 (− 0.009, 0.11)  0.094  0.20 
fT4:tT4 ratio      
Ery-Cd 544  − 0.0003 (− 0.002, 0.001)  0.58  0.67 
U-Cd 542  ¡0.002 (¡0.003, ¡0.001)  <0.001  0.003 
Ery-Pb 544  − 0.001 (− 0.002, 0.001)  0.25  0.33 
Ery-Hg 544  0.001 (0.0001, 0.002)  0.022  0.062 
fT3:tT3 ratio      
Ery-Cd 544  − 0.001 (− 0.021, 0.019)  0.93  
U-Cd 542  ¡0.034 (¡0.052, ¡0.016)  <0.001  0.003 
Ery-Pb 544  − 0.009 (− 0.031, 0.014)  0.45  0.59 
Ery-Hg 544  0.014 (0.002, 0.027)  0.021  0.062 
fT3:fT4 ratio      
Ery-Cd 544  − 0.001 (− 0.007, 0.005)  0.65  0.69 
U-Cd 542  0.005 (− 0.001, 0.010)  0.096  0.20 
Ery-Pb 544  0.004 (− 0.003, 0.011)  0.25  0.33 
Ery-Hg < 1 µg/kg 148  0.003 (− 0.003, 0.009)  0.33  0.46 
Ery-Hg > 1 µg/kg 396  ¡0.013 (¡0.020,-0.006)  <0.001  0.003 
Abbreviations: Ery-Cd, erythrocyte cadmium; Ery-Hg, erythrocyte mercury; Ery-Pb, erythrocyte lead; fT3, free triiodothyronine; fT4, free thyroxine; TSH, thyroid 
stimulating hormone; tT3, total triiodothyronine; tT4, total thyroxine. 
aAdjusted for parity (two groups: ‘0′ and ‘>0′), maternal education (two groups: ‘lower than university’, and ‘university’), maternal pre-pregnancy smoking (two 
groups: ‘never’, and ‘sometimes or daily’). 
bSharpened false discovery rate q-values are a form of adjusted p-values (representing the probability of type I error after adjustment for multiple testing). 
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− 0.001) for T4 and − 0.03 (95% CI: − 0.05, − 0.01) for T3, both associ-
ations corresponding to a 0.18 SD decrease in the respective ratio. 
Maternal erythrocyte Cd, a more short-term exposure marker (3–4 
months), was not significantly associated with any of the hormones, 
neither was erythrocyte Pb. Erythrocyte Hg, however, was non-linearly 
associated with fT3, tT3, and the fT3:fT4 ratio. For Hg levels above 1 µg/ 
kg, a doubling in Hg concentration was associated with a mean decrease 
in both fT3 of − 0.11 pmol/L (95% CI: − 0.16, − 0.05), and in tT3 of 
− 0.11 nmol/L (95% CI: − 0.16, − 0.06), corresponding to a change of 
0.24 and 0.25 SD, respectively, and with a mean decrease of − 0.01 (95% 
CI: − 0.02, − 0.01) in fT3:fT4 (0.23 SD). Also, Hg appeared to be posi-
tively associated with the free:total ratio of both T4 and T3, but the 
associations were no longer significant after FDR adjustment (sharpened 
q-value > 0.05). 
In sensitivity analyses, further adjusting for gestational week at 
sampling and season at sampling had essentially no impact on the 
observed associations (Supplementary Table S3). Similarly, restricting 
the analyses to only never-smokers had very little impact on the 
observed metal-hormone relationships (Supplementary Table S3). 
In the BKMR models including urinary Cd, erythrocyte Pb, and 
erythrocyte Hg as the exposure, urinary Cd had the highest posterior 
inclusion probability (PIP; representing the relative importance of each 
exposure in relation to the outcomes; Supplementary Table S4), in 
relation to fT4, tT4, and the fT4:tT4 ratio, while Hg had the highest PIP 
in relation to fT3, tT3, TSH, and the fT3:tT3 and fT3:fT4 ratios. The 
BKMR did not indicate any joint effects of mixed metal exposure on the 
hormone concentrations (Supplementary Fig. S4A-H), nor any clear in-
teractions between the three metals in relation to the hormones (Sup-
plementary Fig. S5A-H). 
3.5. Influence of iodine and selenium on the metal-hormone associations 
In the multivariable-adjusted regression models, the observed sta-
tistically significant associations between the toxic metals and the hor-
mones were essentially unaffected when also adjusted for maternal 
urinary iodine and plasma selenium concentrations, except for the in-
verse association between Hg and tT4 which became more pronounced 
after the adjustment (Supplementary Table S5). In the BKMR analyses 
including urinary iodine, plasma selenium, and the toxic metals as 
exposure, urinary iodine had the highest PIP in relation to fT4 and TSH, 
while urinary Cd still had the highest PIP for tT4, and Hg for fT3, tT3, 
and the fT3:tT3 and fT3:fT4 ratios (Supplementary Table S4). Plasma 
selenium had the highest PIP in relation to the fT4:tT4 ratio. The BKMR 
did not indicate any overt interactions between the metals and the 
essential elements in relation to the hormone levels (Supplementary 
Fig. S5A-H), although a slightly more pronounced positive association 
between Hg and the fT4:tT4 ratio was observed when selenium was fixed 
at its 10th percentile compared to when selenium was fixed at the 90th 
percentile. This was therefore further explored by including both Hg and 
selenium, as well as a multiplicative interaction term between the two, 
in a regression model (otherwise adjusted as our main model), but this 
did not indicate a statistically significant interaction (p-interaction >
0.10; data not shown). 
4. Discussion 
The present findings suggest that exposure to Cd and MeHg, but not 
Pb, at levels that are globally prevalent through the diet, may affect 
thyroid function in pregnancy. We found that the women’s long-term 
exposure to Cd, measured by concentrations in urine, was positively 
associated with circulating tT4, fT3, and tT3, in a linear manner. 
Erythrocyte Hg concentrations, mainly reflecting MeHg exposure from 
fish consumption, was inversely associated with fT3, tT3, and the fT3: 
fT4 ratio, at concentrations above 1 µg/kg, which was found in 73% of 
the women. We found no associations between the women’s Pb exposure 
and their hormone levels, but the Pb exposure was low [median in 
erythrocytes: 11 µg/kg, corresponding to approximately 4.3 µg/L in 
whole blood (Gustin et al. 2020)]. The BKMR analysis did not indicate 
any mixed exposure effects of the toxic metals, or any clear interactions 
with iodine and selenium, in relation to the hormone concentrations, 
despite a fairly wide variation in both urinary iodine and plasma sele-
nium concentrations, including insufficiency (Stråvik et al, submitted). 
Thus, the potential effects of Cd and Hg on maternal thyroid function did 
not appear to be substantially aggravated by poor iodine and/or sele-
nium status. 
Beside the positive associations with tT4, fT3, and tT3, urinary Cd, 
above the concentration of 0.09 µg/L (which 63% of the women had), 
was also positively associated with TSH, although not clearly significant 
after FDR adjustment. These findings are in accordance with the results 
from a large US study, including women and men from the National 
Health and Nutrition Examination Survey (NHANES; n = 4409) (Chen 
et al. 2013). In a Chinese study by Wang et al. (2020), maternal urinary 
Cd concentrations in late first trimester (median: 0.57 µg/L; n = 389) 
were positively associated with TSH levels in the second trimester (mean 
gestational week: 24.6), but not with T4 or T3. In another Chinese study 
(Sun et al. 2019), urinary Cd in early pregnancy (before gestational week 
18) was not associated with concurrent levels of T4, T3, or TSH, despite 
a similar Cd exposure (median: 0.62 µg/L; n = 675). However, it should 
be noted that comparing Cd-related associations with T4, T3, and TSH 
between different stages of pregnancy is not appropriate because of the 
drastic changes in thyroid physiology that occurs in pregnancy, espe-
cially during the first and second trimester (Glinoer 1997; Korevaar et al. 
2017). 
The mechanisms of action by which toxic metals may affect levels of 
thyroid hormones are largely unknown. It has been suggested that 
metals like Cd may accumulate in the thyroid, due to its high expression 
of metallothionein (Suzuki et al. 1996). However, we would then have 
anticipated a negative association between Cd and T4, as T4 is produced 
in the thyroid, but instead we observed the opposite with both T4 and T3 
across the whole range of Cd exposure, more indicative of indirect ef-
fects of Cd. Further, we observed inverse associations between urinary 
Cd and the fT4:tT4 and fT3:tT3 ratios, suggesting a relatively higher 
increase in total hormone levels compared to free levels, with increasing 
Cd. The major thyroid hormone transport protein is thyroxine-binding 
globulin (TBG). In pregnancy, the levels of TBG increase drastically 
due to rising estrogen levels (Glinoer 1997). Cadmium is known to have 
estrogen-mimicking properties (Johnson et al. 2003), which may 
explain the observed associations. Also, Cd exposure has been shown to 
inhibit the expression of thyroid hormone receptors and type III deio-
dinase in experimental studies (Wu et al. 2017). 
In contrast to the Cd exposure, the women’s exposure to MeHg [>1 
µg Hg/kg in erythrocytes, roughly corresponding to 0.40–4.2 µg/L in 
whole blood (Gustin et al. 2020)] was inversely associated with both fT3 
and tT3, and with the fT3:fT4 ratio. Non-linear associations, with no 
observable association up to a certain exposure level, are commonly 
observed for non-carcinogenic toxicants and may be indicative of 
threshold effects. The few existing studies assessing thyroid function in 
relation to MeHg exposure in pregnancy are either very small or suffer 
from certain methodological issues. In a study of 75 pregnant women in 
Slovakia, maternal blood MeHg (median: 0.22 µg/L) at delivery was 
inversely associated with tT3 in sub-group analyses (Ursinyova et al. 
2012). In a much larger Spanish study of 1407 mothers (Llop et al. 
2015), total Hg concentrations in umbilical cord blood (geometric mean: 
7.7 µg/L) was nearly significantly inversely associated with tT3 in early 
pregnancy (B: − 0.05; 95% CI: − 0.10, 0.01). However, the fact that the 
exposure (cord blood Hg) was measured several months after the 
outcome (early pregnancy) raises concern. 
In experimental studies, MeHg has been shown to inhibit type II 
deiodinase activity (Mori et al. 2007), which is responsible for con-
verting T4 into T3, and inhibition of its activity could potentially lead to 
reduced T3 levels. The fact that we also observed an inverse association 
between erythrocyte Hg and the fT3:fT4 ratio is further indicative of 
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reduced type II deiodinase activity with increasing MeHg exposure. 
Also, increased placental type III deiodinase activity, responsible for 
inactivation of T3 (Huang and Bianco 2008), has been observed in 
pregnant mice exposed to MeHg (Watanabe et al. 1999). However, there 
were no discernable effect of MeHg exposure on maternal plasma T3 
levels in the studied mice. 
The strengths of this study include the individual exposure assess-
ments of three toxic metals and two thyroid-related essential elements 
by measuring concentrations of suitable biomarkers with a highly sen-
sitive ICP-MS method. We observed generally low metal concentrations, 
yet only two samples had a concentration below the LOD for Hg, while 
Pb and Cd were detected in all samples. We were also able to adjust for 
several important covariates, as well as maternal iodine and selenium 
concentrations. A major limitation is that only about 10% of all the 
women (about 5000) giving birth at Sunderby hospital during the 
recruitment period participated in the study (Englund-Ögge et al., sub-
mitted). Consequently, the participating women may not be represen-
tative of pregnant women in the area in general. However, the exposure 
to Cd and Hg appears similar to those previously reported for pregnant 
women in southern and central Sweden (Akesson et al. 2002; Vahter 
et al. 2000), and to the Cd exposure reported for women in reproductive 
age in northern Sweden (Wennberg et al. 2017). Another limitation is 
that erythrocyte Hg was not speciated, why we cannot exclude that a 
small fraction of erythrocyte Hg was inorganic Hg, although part of that 
would then be due to demethylation of MeHg (Berglund et al. 2005). 
Since dental amalgams, a main source of inorganic Hg exposure 
(Bjornberg et al. 2005; Clarkson and Magos 2006), was gradually phased 
out in the 1990s in Sweden, it seems unlikely that the women were 
exposed to inorganic Hg to any significant extent. Further, we used 
single spot-urine samples to assess maternal iodine status. Urinary 
iodine is a short-term biomarker that can vary substantially within and 
between days and it is therefore suboptimal for assessing individual 
iodine status. In the present study, we measured free thyroid hormone 
concentrations in plasma by immunoassays which may be sensitive to 
the pregnancy-related increase in TBG, however, it was not possible to 
calculate the fT4 or fT3 index (Villanger et al. 2017). Finally, this is a 
cross-sectional observational study, why the causality is not known, and, 
as with all observational studies, we cannot exclude that our findings 
were influenced by unmeasured or residual confounding. 
5. Conclusion 
The present findings indicate that exposure to Cd and MeHg, at levels 
globally prevalent through the diet, may interfere with maternal thyroid 
function during pregnancy. This is of public health concern as even fairly 
small changes in the hormones during pregnancy may be disadvanta-
geous for both maternal and fetal health. The associations appeared 
independent of the iodine and selenium levels, which both were low 
among many of the women. Studies on the potential impact on fetal 
thyroid hormones are warranted, especially as MeHg is actively trans-
ported across the placenta (EFSA 2012) and Cd accumulates in the 
placenta, a crucial site of type III deiodinase activity (Huang et al. 2003). 
Importantly, since exposure to Cd and MeHg mainly comes from the 
consumption of food with high nutritional value, such as whole-grain 
cereals and seafood (Gustin et al. 2020), our findings highlight the 
importance of reducing food contamination. 
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